|
KIAA1143 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.768900E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.076080E-03 |
| Normal-vs-Stage2 |
1.407890E-02 |
| Normal-vs-Stage3 |
8.437600E-02 |
| Normal-vs-Stage4 |
9.61539999999594E-05 |
| Stage1-vs-Stage2 |
4.389000E-01 |
| Stage1-vs-Stage3 |
7.973600E-01 |
| Stage1-vs-Stage4 |
9.904300E-02 |
| Stage2-vs-Stage3 |
7.039400E-01 |
| Stage2-vs-Stage4 |
6.643800E-01 |
| Stage3-vs-Stage4 |
3.711400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.029900E-04 |
| Normal-vs-AfricanAmerican |
7.830000E-04 |
| Normal-vs-Asian |
2.370700E-04 |
| Caucasian-vs-AfricanAmerican |
4.618800E-01 |
| Caucasian-vs-Asian |
3.181600E-01 |
| AfricanAmerican-vs-Asian |
3.784800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.84200000003165E-06 |
| Normal-vs-Female |
6.418200E-01 |
| Male-vs-Female |
7.116000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.848900E-04 |
| Normal-vs-Extreme_Weight |
3.597100E-04 |
| Normal-vs-Obese |
1.080990E-01 |
| Normal-vs-Extreme_Obese |
4.465900E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.615400E-01 |
| Normal_Weight-vs-Obese |
1.202180E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.626000E-01 |
| Extreme_Weight-vs-Obese |
1.125630E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.813800E-01 |
| Obese-vs-Extreme_Obese |
2.563800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.329850E-01 |
| Normal-vs-Age(41-60Yrs) |
7.762200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.51508999999272E-05 |
| Normal-vs-Age(81-100Yrs) |
3.659200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.250800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.604400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.456400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.012000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.029640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.530000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.083300E-03 |
| Normal-VS-Type2 PRCC |
5.8645999945206E-08 |
| Normal-VS-KIRP CIMP |
5.549600E-01 |
| Normal-VS-Unclassified PRCC |
5.273400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.202000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.068800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.297600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.212000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.627900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.890000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.77270000012442E-07 |
| Normal-vs-N1 |
1.937980E-02 |
| Normal-vs-N2 |
1.366830E-04 |
| N0-vs-N1 |
1.682210E-01 |
| N0-vs-N2 |
5.858400E-01 |
| N1-vs-N2 |
2.675800E-01 |
|
|
